Sunday, July 12, 2026

pharma · Chronic Spontaneous Urticaria · Asthma

Novartis India

Novartis Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Spontaneous Urticaria, Asthma, Systemic Lupus Erythematosus, Breast Cancer, Multiple Sclerosis. NovaP

Mumbai, IN HQ
1996 Founded
2,240 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Mumbai, IN
Founded
1996
Employees
2,240
Programs
341
Drugs
317
Patents
0
Clinical program

Blood draw for Lp(a)

Unknown · other · Cardiovascular Disease and Lipoprotein(a)

Blood draw for Lp(a) for Cardiovascular Disease and Lipoprotein(a) is a Unknown program (other) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Internal code CTQJ230A12001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Novartis Pharmaceuticals
Phase
Unknown
Modality
other
Indication
Cardiovascular Disease and Lipoprotein(a)
Status
completed
Trials
1